Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Botulinum neurotoxin E (BoNT/E) can cause paralysis in humans and animals by blocking neurotransmitter release from presynaptic nerve terminals. How this toxin targets and enters neurons is not known. Here we identified two isoforms of the synaptic vesicle protein SV2, SV2A and SV2B, as the protein receptors for BoNT/E. BoNT/E failed to enter neurons cultured from SV2A/B knockout mice; entry was restored by expressing SV2A or SV2B, but not SV2C. Mice lacking SV2B displayed reduced sensitivity to BoNT/E. The fourth luminal domain of SV2A or SV2B alone, expressed in chimeric receptors by replacing the extracellular domain of the low-density lipoprotein receptor, can restore the binding and entry of BoNT/E into neurons lacking SV2A/B. Furthermore, we found disruption of a N-glycosylation site (N573Q) within the fourth luminal domain of SV2A rendered the mutant unable to mediate the entry of BoNT/E and also reduced the entry of BoNT/A. Finally, we demonstrate that BoNT/E failed to bind and enter ganglioside-deficient neurons; entry was rescued by loading exogenous gangliosides into neuronal membranes. Together, the data reported here demonstrate that glycosylated SV2A and SV2B act in conjunction with gangliosides to mediate the entry of BoNT/E into neurons.

[1]  P. Scheiffele,et al.  Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons , 2008, Journal of Neuroscience Methods.

[2]  K. Aoki.  Botulinum toxin: a successful therapeutic protein. , 2004, Current medicinal chemistry.

[3]  Eric A. Johnson,et al.  Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells , 2003, The Journal of cell biology.

[4]  S. Carlson,et al.  The SV2 Protein of Synaptic Vesicles Is a Keratan Sulfate Proteoglycan , 1993, Journal of neurochemistry.

[5]  S. Chiu,et al.  Temperature-Sensitive Neuromuscular Transmission in Kv1.1 Null Mice: Role of Potassium Channels under the Myelin Sheath in Young Nerves , 1998, The Journal of Neuroscience.

[6]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[7]  Axel T. Brunger,et al.  Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity , 2006, Nature.

[8]  Kazuki Sato,et al.  The high‐affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a , 1996, FEBS letters.

[9]  M. Iwamori,et al.  Interaction between Clostridium botulinum neurotoxin and gangliosides. , 1980, Biochimica et biophysica acta.

[10]  R. Jahn,et al.  Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC‐1/syntaxin. , 1993, The EMBO journal.

[11]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[12]  M. Montal,et al.  Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes , 2007, Proceedings of the National Academy of Sciences.

[13]  A. Omori,et al.  Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. , 1994, The Journal of biological chemistry.

[14]  M. Linial,et al.  Brain contains two forms of synaptic vesicle protein 2. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Silberstein,et al.  Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. , 2004, Clinics in dermatology.

[16]  M. Feany,et al.  The synaptic vesicle protein SV2 is a novel type of transmembrane transporter , 1992, Cell.

[17]  R Janz,et al.  SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family , 1999, Neuroscience.

[18]  T. Nishiki,et al.  Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. , 1998, Microbial pathogenesis.

[19]  R. Kelly,et al.  Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells , 1985, The Journal of cell biology.

[20]  Thomas C. Südhof,et al.  Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 , 1993, Nature.

[21]  J. Barbieri,et al.  Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. , 2007, Biochemistry.

[22]  T. Südhof,et al.  Membrane fusion and exocytosis. , 1999, Annual review of biochemistry.

[23]  Reinhard Jahn,et al.  SNAREs — engines for membrane fusion , 2006, Nature Reviews Molecular Cell Biology.

[24]  G. Sakaguchi,et al.  Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids. , 1986, Biochemical and biophysical research communications.

[25]  Eric A. Johnson,et al.  Jcb: Article , 2022 .

[26]  J. Rothman,et al.  Implications of the SNARE hypothesis for intracellular membrane topology and dynamics , 1994, Current Biology.

[27]  C. Schengrund,et al.  Botulinum Neurotoxin A Activity Is Dependent upon the Presence of Specific Gangliosides in Neuroblastoma Cells Expressing Synaptotagmin I* , 2002, The Journal of Biological Chemistry.

[28]  Eric A. Johnson,et al.  SV2 Is the Protein Receptor for Botulinum Neurotoxin A , 2006, Science.

[29]  H. Bigalke,et al.  Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin G* , 2004, Journal of Biological Chemistry.

[30]  E. Johnson,et al.  Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. , 1999, Annual review of microbiology.

[31]  C. Schengrund,et al.  Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b. , 2004, Biochemistry.

[32]  J. Dolly,et al.  Two Protein Trafficking Processes at Motor Nerve Endings Unveiled by Botulinum Neurotoxin E , 2007, Journal of Pharmacology and Experimental Therapeutics.

[33]  F. Benfenati,et al.  Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin , 1992, Nature.

[34]  Kazuro Furukawa,et al.  Complex Gangliosides at the Neuromuscular Junction Are Membrane Receptors for Autoantibodies and Botulinum Neurotoxin But Redundant for Normal Synaptic Function , 2002, The Journal of Neuroscience.

[35]  Brian D. Hale,et al.  Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Markus Missler,et al.  SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release , 1999, Neuron.

[37]  R. Jahn,et al.  Calcium-dependent interaction of the cytoplasmic region of synaptotagmin with membranes. Autonomous function of a single C2-homologous domain. , 1994, The Journal of biological chemistry.

[38]  K. Takamiya,et al.  Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. , 1999, Biochimica et biophysica acta.

[39]  B. Davletov,et al.  The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves , 2006, FEBS letters.

[40]  I. Barker,et al.  Persistence of Clostridium botulinum neurotoxin type E in tissues from selected freshwater fish species: implications to public health. , 2006, Journal of food protection.

[41]  M. Montal,et al.  Translocation of botulinum neurotoxin light chain protease through the heavy chain channel , 2003, Nature Structural Biology.

[42]  F. Benfenati,et al.  Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. , 1993, The Journal of biological chemistry.

[43]  K. Takeuchi,et al.  Binding of Clostridium botulinum Type C and D Neurotoxins to Ganglioside and Phospholipid , 2005, Journal of Biological Chemistry.

[44]  R. Scheller,et al.  SV2, a brain synaptic vesicle protein homologous to bacterial transporters. , 1992, Science.

[45]  H. Bigalke,et al.  The HCC‐domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction , 2003, Molecular microbiology.

[46]  R. Scheller,et al.  Differential expression of synaptic vesicle protein 2 (SV2) isoforms , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  L. Simpson,et al.  Identification of the major steps in botulinum toxin action. , 2004, Annual review of pharmacology and toxicology.

[48]  E. C. Dickson.  Botulism , 1916 .

[49]  J. Crawley,et al.  A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. , 1999, The Journal of clinical investigation.

[50]  T. Südhof,et al.  Synaptotagmin I: A major Ca2+ sensor for transmitter release at a central synapse , 1994, Cell.

[51]  B. Ehrlich,et al.  Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Schiavo,et al.  Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.

[53]  G. Schiavo,et al.  Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. , 1993, The Journal of biological chemistry.

[54]  L. Raiteri,et al.  Traffic of Botulinum Toxins A and E in Excitatory and Inhibitory Neurons , 2007, Traffic.

[55]  R. Stevens,et al.  Structural basis of cell surface receptor recognition by botulinum neurotoxin B , 2006, Nature.

[56]  C. Montecucco.  How do tetanus and botulinum toxins bind to neuronal membranes , 1986 .

[57]  J. Black,et al.  Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization , 1984, Nature.

[58]  G. Schiavo,et al.  Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. , 1994, The Journal of biological chemistry.

[59]  J. Keller,et al.  Uptake of botulinum neurotoxin into cultured neurons. , 2004, Biochemistry.

[60]  T. Weil,et al.  Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept , 2007, Proceedings of the National Academy of Sciences.

[61]  廣瀬雄一,et al.  Neuroscience , 2019, Workplace Attachments.

[62]  J. Rothman,et al.  Patterns of synaptic activity in neural networks recorded by light emission from synaptolucins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.